Huiling Yang

2.3k total citations
65 papers, 1.7k citations indexed

About

Huiling Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huiling Yang has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 23 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Huiling Yang's work include Cancer-related Molecular Pathways (13 papers), RNA modifications and cancer (11 papers) and Ubiquitin and proteasome pathways (10 papers). Huiling Yang is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), RNA modifications and cancer (11 papers) and Ubiquitin and proteasome pathways (10 papers). Huiling Yang collaborates with scholars based in China, United States and Australia. Huiling Yang's co-authors include Weiyi Fang, François X. Claret, Yunbao Pan, Ruiying Zhao, Xin Li, Mong‐Hong Lee, Kai‐Tai Yao, Weiren Luo, Zhen Liu and Zhen Liu and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Huiling Yang

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiling Yang China 26 1.3k 542 475 150 148 65 1.7k
Angélica Figueroa Spain 25 1.2k 0.9× 559 1.0× 439 0.9× 100 0.7× 146 1.0× 46 1.7k
Xiaoyan Xu China 23 1.3k 1.0× 487 0.9× 433 0.9× 225 1.5× 198 1.3× 79 1.8k
Evan C. Lien United States 17 1.4k 1.0× 777 1.4× 393 0.8× 143 1.0× 207 1.4× 28 2.0k
Chi-Hung Huang Taiwan 15 1.2k 0.9× 497 0.9× 713 1.5× 110 0.7× 127 0.9× 27 1.8k
Megumi Iiizumi United States 17 1.1k 0.8× 674 1.2× 494 1.0× 222 1.5× 257 1.7× 19 1.7k
Fatih Ceteci Germany 14 923 0.7× 503 0.9× 413 0.9× 151 1.0× 224 1.5× 17 1.4k
Limei Liu China 22 1.1k 0.9× 507 0.9× 565 1.2× 182 1.2× 125 0.8× 42 1.7k
Flore Kruiswijk United States 6 1.1k 0.8× 651 1.2× 408 0.9× 117 0.8× 119 0.8× 8 1.6k
Shujuan Shao China 23 1.3k 1.0× 690 1.3× 311 0.7× 162 1.1× 205 1.4× 61 1.8k
Xiaobing Deng United States 24 1.2k 0.9× 300 0.6× 436 0.9× 195 1.3× 222 1.5× 39 1.8k

Countries citing papers authored by Huiling Yang

Since Specialization
Citations

This map shows the geographic impact of Huiling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Yang more than expected).

Fields of papers citing papers by Huiling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Yang. The network helps show where Huiling Yang may publish in the future.

Co-authorship network of co-authors of Huiling Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Huiling Yang. A scholar is included among the top collaborators of Huiling Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiling Yang. Huiling Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Zhongshan, Huiling Yang, Yupei Zhang, et al.. (2025). Enhancing oral bioavailability and reducing gastrointestinal toxicity of Tilianin via folic acid-modified nanocrystal liposomes. Journal of Drug Delivery Science and Technology. 108. 106914–106914. 2 indexed citations
2.
Li, Wanyu, Yan Zhuo, Zhihao Chen, et al.. (2024). Hydrogel based on M1 macrophage lysate and alginate loading with oxaliplatin for effective immunomodulation to inhibit melanoma progression, recurrence and metastasis. International Journal of Biological Macromolecules. 280(Pt 2). 135542–135542. 3 indexed citations
3.
Zhang, Ziyan, Huang Huang, Beixian Zhou, et al.. (2024). SIX4 Activation in Inflammatory Response Drives the Transformation of Colorectal Epithelium into Inflammation and Tumor via Feedback-Enhancing Inflammatory Signaling to Induce Tumor Stemness Signaling. International Journal of Biological Sciences. 20(12). 4618–4634. 2 indexed citations
4.
Li, Wanyu, Yan Zhuo, Dan Wang, et al.. (2024). A cross-linked macropore hydrogel based on M1 macrophage lysate and alginate regulates tumor-associated macrophages for the treatment of melanoma. International Journal of Biological Macromolecules. 269(Pt 2). 132089–132089. 6 indexed citations
5.
Su, Yun, Yuting Ma, Yubing Wang, et al.. (2024). Downregulated CCND3 Is a Key Event Driving Lung Adenocarcinoma Metastasis during Acquired Cisplatin Resistance. International Journal of Biological Sciences. 21(2). 708–724.
7.
Li, Wanyu, Yanan Chen, Kun He, et al.. (2022). The Apoptosis of Liver Cancer Cells Promoted by Curcumin/TPP-CZL Nanomicelles With Mitochondrial Targeting Function. Frontiers in Bioengineering and Biotechnology. 10. 804513–804513. 28 indexed citations
8.
Liu, Jiahao, Huiling Yang, Zhe Hu, et al.. (2022). The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma. Acta Pharmacologica Sinica. 43(10). 2687–2695. 28 indexed citations
10.
Su, Jie, Zijun Huo, Julian A. Gingold, et al.. (2019). Genomic Integrity Safeguards Self-Renewal in Embryonic Stem Cells. Cell Reports. 28(6). 1400–1409.e4. 10 indexed citations
11.
Wang, Sumei, Rong Zhang, François X. Claret, & Huiling Yang. (2014). Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation. Molecular Cancer Therapeutics. 13(12). 3163–3174. 53 indexed citations
12.
13.
Zhen, Yan, Yanfen Ye, Xiaoli Yu, et al.. (2013). Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma. PLoS ONE. 8(6). e64976–e64976. 31 indexed citations
14.
Jiang, Qingping, Huiling Yang, Chao Cheng, et al.. (2013). Decreased P27 protein expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma. Diagnostic Pathology. 8(1). 212–212. 3 indexed citations
15.
Pan, Yunbao, Qingxiu Zhang, Ling Tian, et al.. (2012). Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma. Cancer Research. 72(7). 1890–1900. 61 indexed citations
16.
Xue, Yuwen, Jian Chen, Liem Phan, et al.. (2012). HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle. 11(22). 4181–4190. 28 indexed citations
17.
Wu, Aibing, Bin Wu, Jinsong Guo, et al.. (2011). Elevated expression of CDK4 in lung cancer. Journal of Translational Medicine. 9(1). 38–38. 81 indexed citations
18.
Hy, Yang, et al.. (2007). Roles for negative cell regulator 14-3-3σ in control of MDM2 activities. Oncogene. 26(52). 7355–7362. 45 indexed citations
20.
She, Miaorong, Huiling Yang, Lily Sun, & Sai‐Ching J. Yeung. (2006). Redox control of manumycin A-induced apoptosis in anaplastic thyroid cancer cells: Involvement of the xenobiotic apoptotic pathway. Cancer Biology & Therapy. 5(3). 275–280. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026